ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2025 ANS Winter Conference & Expo
November 9–12, 2025
Washington, DC|Washington Hilton
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Oct 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
November 2025
Nuclear Technology
October 2025
Fusion Science and Technology
Latest News
Sellafield awards $3.86B in infrastructure contracts to three companies
Sellafield Ltd., the site license company overseeing the decommissioning of the U.K.’s Sellafield nuclear site in Cumbria, England, announced the award of £2.9 billion (about $3.86 billion) in infrastructure support contracts to the companies of Morgan Sindall Infrastructure, Costain, and HOCHTIEF (UK) Construction.
Jérôme M. Verbeke, Allen S. Chen, Jasmina L. Vujic, Ka-Ngo Leung
Nuclear Technology | Volume 131 | Number 2 | August 2000 | Pages 269-276
Technical Paper | Radiation Biology and Medicine | doi.org/10.13182/NT00-A3116
Articles are hosted by Taylor and Francis Online.
A monoenergetic neutron beam simulation study was carried out to determine the optimal neutron energy range for treatment of rheumatoid arthritis using radiation synovectomy. The goal of the treatment is the ablation of diseased synovial membranes in joints such as knees and fingers. This study focuses on human knee joints. Two figures of merit are used to measure the neutron beam quality, the ratio of the synovium-absorbed dose to the skin-absorbed dose, and the ratio of the synovium-absorbed dose to the bone-absorbed dose. It was found that (a) thermal neutron beams are optimal for treatment and that (b) similar absorbed dose rates and therapeutic ratios are obtained with monodirectional and isotropic neutron beams. Computation of the dose distribution in a human knee requires the simulation of particle transport from the neutron source to the knee phantom through the moderator. A method was developed to predict the dose distribution in a knee phantom from any neutron and photon beam spectra incident on the knee. This method was revealed to be reasonably accurate and enabled one to reduce the particle transport simulation time by a factor of 10 by modeling the moderator only.